Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
(1) Mitochondrial disorders(2) are a well-recognized cause; however, to our knowledge this is the first time that such extensive intracranial calcium deposits have been described in a patient with a POLG1 mutation.
|
23836942 |
2013 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Mitochondrial disorder was clinically suspected and a homozygous c.2243G>C mutation (p.Trp748Ser) was discovered in the POLG1 gene.
|
23248042 |
2012 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
POLG mutations in sporadic mitochondrial disorders with multiple mtDNA deletions.
|
14635118 |
2003 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
POLG1 is a major disease gene in mitochondrial disorders.
|
15689359 |
2005 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
POLG, the gene encoding the catalytic subunit of pol gamma, is a major locus for a wide spectrum of mitochondrial diseases with more than 100 known disease mutations.
|
19513667 |
2009 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
POLG1 encodes mitochondrial DNA polymerase and is one of the causative genes for a Mendelian-inheritance mitochondrial disease, which is occasionally accompanied by mood disorders.
|
27987238 |
2017 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
POLG mutations are the most common cause of inherited mitochondrial disorders, with as many as 2% of the population carrying these mutations.
|
30451971 |
2019 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
A POLG Y955C point mutation causes human chronic progressive external ophthalmoplegia (CPEO), a mitochondrial disease with eye muscle weakness and mtDNA defects.
|
17310215 |
2007 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
About 150 mutations in the human POLG have been identified in patients with mitochondrial diseases such as Alpers syndrome, progressive external ophthalmoplegia, and ataxia-neuropathy syndromes.
|
20927567 |
2011 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Alpers syndrome is one of the most common phenotypes of mitochondrial disorders in early childhood and has been associated with pathogenic mutations in POLG1.
|
22237560 |
2012 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Among adult POLG1-associated mitochondrial disease, the main clinical feature is chronic progressive external ophthalmoplegia.
|
30936349 |
2019 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
An analysis of the POLG1 gene should be performed for all patients with suspected mitochondrial disease before the introduction of valproate therapy, and treatment with valproic acid should be avoided in these patients.
|
25065347 |
2014 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Clinical diagnosis of POLG-related disorders can be challenging because the phenotypic spectrums are heterogeneous which can mimic different types of mitochondrial disorders.
|
26169155 |
2015 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
CTD_human |
Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma.
|
18716558 |
2008 |
Mitochondrial Diseases
|
0.500 |
CausalMutation
|
group |
CLINVAR |
Decreased male reproductive success in association with mitochondrial dysfunction.
|
28812649 |
2017 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Defects in the mitochondrial DNA replication enzyme, polymerase γ, are an important cause of mitochondrial disease with ∼25% of all adult diagnoses attributed to mutations in the POLG gene.
|
22189570 |
2012 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Diseases due to mutations of POLG gene, encoding the mitochondrial DNA polymerase, are reputed to have very diverse clinical presentations and have been proposed to cause up to 25% adult mitochondrial diseases.
|
25118206 |
2015 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Distal upper limb myopathy/cachexia is not previously described with dominant POLG mutations and our observations further highlight the diverse clinical spectrum of POLG-related mitochondrial disorders.
|
22933815 |
2013 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Fatal human herpesvirus 6-associated encephalitis in two boys with underlying POLG mitochondrial disorders.
|
25160553 |
2014 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Genes encoding the DNA helicase TWINKLE (C10orf2) or the two subunits of mtDNA polymerase γ (POLγ) (POLG1 and POLG2) have a direct effect on the mitochondrial DNA replication machinery and were reported in many mitochondrial disorders.
|
24011957 |
2014 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Infectious stress triggers a POLG-related mitochondrial disease.
|
31655921 |
2020 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Many mutations in POLG, the gene that encodes pol γ, have been associated with mitochondrial diseases such as myocerebrohepatopathy spectrum (MCHS) disorders, Alpers-Huttenlocher syndrome, myoclonic epilepsy myopathy sensory ataxia (MEMSA), ataxia neuropathy spectrum (ANS), and progressive external ophthalmoplegia (PEO).
|
23545419 |
2013 |
Mitochondrial Diseases
|
0.500 |
Biomarker
|
group |
BEFREE |
Missense mutations in the gene for polymerase gamma 1 (POLG1) cause a number of phenotypically heterogeneous mitochondrial diseases, most commonly progressive external ophthalmoplegia, and are characterized by the accumulation of multiple, large-scale deletions of mitochondrial DNA.
|
20513108 |
2010 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders.
|
17088268 |
2006 |
Mitochondrial Diseases
|
0.500 |
GeneticVariation
|
group |
LHGDN |
Molecular studies in the POLG gene should be addressed in patients with mitochondrial disease, particularly in those with PEO, and multiple mtDNA deletions.
|
16401742 |
2006 |